Literature DB >> 5495387

Immunologic effects of cyclophosphamide treatment in rheumatoid arthritis.

F P Alepa, N J Zvaifler, A J Sliwinski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5495387     DOI: 10.1002/art.1780130604

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  8 in total

1.  Treatment of rheumatoid arthritis with levamisole: long-term results and immune changes.

Authors:  L A Runge; R S Pinals; R H Tomar
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

2.  Treatment of active chronic hepatitis with cyclophosphamide.

Authors:  R Naccarato; R Farini; M Chiaramonte; U Fagiolo; G C Sturniolo
Journal:  Postgrad Med J       Date:  1974-01       Impact factor: 2.401

3.  Immunoresponsiveness of patients with rheumatoid arthritis receiving cyclophosphamide or gold salts.

Authors:  J S Strong; B A Bartholomew; C J Smyth
Journal:  Ann Rheum Dis       Date:  1973-05       Impact factor: 19.103

4.  Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations.

Authors:  J E Balow; D L Hurley; A S Fauci
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

5.  Studies on dengue 2 virus infection in cyclophosphamide-treated rhesus monkeys.

Authors:  N J Marchette; T O'Rourke; S B Halstead
Journal:  Med Microbiol Immunol       Date:  1980-02       Impact factor: 3.402

6.  Investigations on the influence of cyclophosphamide, gold sodium thiomalate and D-penicillamine on nystatin oedema and adjuvant arthritis.

Authors:  E Arrigoni-Martelld; E Bramm
Journal:  Agents Actions       Date:  1975-08

7.  Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.

Authors:  R J ten Berge; H K van Walbeek; P T Schellekens
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

8.  Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells.

Authors:  L P Zhu; T R Cupps; G Whalen; A S Fauci
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.